Consumer medicine information

Staphylex

Flucloxacillin

BRAND INFORMATION

Brand name

Staphylex

Active ingredient

Flucloxacillin

Schedule

S4

 

Consumer medicine information (CMI) leaflet

Please read this leaflet carefully before you start using Staphylex.

SUMMARY CMI

STAPHYLEX®

Consumer Medicine Information (CMI) summary

The full CMI on the next page has more details. If you are worried about taking this medicine, speak to your doctor or pharmacist.

1. Why am I taking STAPHYLEX?

STAPHYLEX contains the active ingredient flucloxacillin (as sodium monohydrate). STAPHYLEX is used to treat infections in different parts of the body caused by bacteria. For more information, see Section 1. Why am I taking STAPHYLEX? in the full CMI.

2. What should I know before I take STAPHYLEX?

Do not take if you have ever had an allergic reaction to STAPHYLEX or any of the ingredients listed at the end of the CMI.
Talk to your doctor if you have any other medical conditions, take any other medicines, or are pregnant or plan to become pregnant or are breastfeeding. For more information, see Section 2. What should I know before I take STAPHYLEX? in the full CMI.

3. What if I am taking other medicines?

Some medicines may interfere with STAPHYLEX and affect how it works.
A list of these medicines is in Section 3. What if I am taking other medicines? in the full CMI.

4. How do I take STAPHYLEX?

  • Usual adult dose: 250 mg every 6 hours.
  • Usual child dose: 2 to 10 years: half of the adult dose.
  • Usual child dose: under 2 years: quarter of the adult dose.
  • Take STAPHYLEX 30 minutes to 1 hour before food.

More instructions can be found in Section 4. How do I take STAPHYLEX? in the full CMI.

5. What should I know while taking STAPHYLEX?

Things you should do
  • Remind any doctor, dentist or pharmacist you visit that you are taking STAPHYLEX.
  • If you get a sore, white mouth or tongue while taking or soon after stopping STAPHYLEX, tell your doctor. Also tell your doctor if you get vaginal itching or discharge.
Things you should not do
  • Do not take any medicine for diarrhoea without first checking with your doctor or pharmacist.
  • Do not stop taking your medicine or lower the dosage without checking with your doctor.
Driving or using machines
  • Be careful before you drive or use any machines or tools until you know how STAPHYLEX affects you.
Looking after your medicine
  • Keep your capsules in a cool dry place where the temperature stays below 25°C.
  • Keep it where young children cannot reach it.

For more information, see Section 5. What should I know while taking STAPHYLEX? in the full CMI.

6. Are there any side effects?

Tell your doctor or pharmacist if you have any of these: nausea; vomiting or an upset stomach; diarrhoea; a mild rash; oral thrush (white, furry sore tongue and mouth); vaginal thrush (sore and itchy vagina and/or vaginal discharge). Stop taking STAPHYLEX and tell your doctor immediately, or go to Accident and Emergency at the nearest hospital if you notice any of these: any type of skin rash, itching or hives; swelling of the face, lips, tongue or other parts of the body; shortness of breath, wheezing or troubled breathing. Tell your doctor immediately, or go straight to the Emergency Department at your nearest hospital if you notice any of these: watery and severe diarrhoea, which may also be bloody; severe stomach cramps; tiredness, headaches, being short of breath when exercising, dizziness and looking pale; bleeding or bruising more easily than normal; frequent infections such as fever, chills, sore throat or mouth ulcers; yellowing of the eyes or skin (jaundice); painful, swollen joints; aching muscles, muscle tenderness or weakness, not caused by exercise; irregular heart beat; dark or cloudy urine, blood in the urine.
For more information, including what to do if you have any side effects, see Section 6. Are there any side effects? in the full CMI.



FULL CMI

STAPHYLEX®

Active ingredient(s): flucloxacillin (as sodium monohydrate)


Consumer Medicine Information (CMI)

This leaflet provides important information about taking STAPHYLEX. You should also speak to your doctor or pharmacist if you would like further information or if you have any concerns or questions about taking STAPHYLEX.

Where to find information in this leaflet:

1. Why am I taking STAPHYLEX?
2. What should I know before I take STAPHYLEX?
3. What if I am taking other medicines?
4. How do I take STAPHYLEX?
5. What should I know while taking STAPHYLEX?
6. Are there any side effects?
7. Product details

1. Why am I taking STAPHYLEX?

STAPHYLEX contains the active ingredient flucloxacillin (as sodium monohydrate).

It is used to treat infections in different parts of the body caused by bacteria.

It is an antibiotic that belongs to a group of medicines called penicillins. These medicines work by killing the bacteria that are causing your infection.

STAPHYLEX will not work against infections caused by viruses, such as colds.

Ask your doctor if you have any questions about why this medicine has been prescribed for you.

Your doctor may have prescribed STAPHYLEX for another reason.

This medicine is not addictive.

2. What should I know before I take STAPHYLEX?

Warnings

Flucloxacillin can cause severe liver damage, particularly in older patients and those who take it for more than 14 days.

Do not take STAPHYLEX if:

  • you are allergic to:
    - any medicine containing flucloxacillin
    - any other penicillin medicines or cephalosporins
    - beta-lactam antibiotics including imipenem and aztreonam
    - any of the ingredients listed at the end of this leaflet.

Some of the symptoms of an allergic reaction may include:

  • shortness of breath
  • wheezing or difficulty in breathing
  • swelling of the face, lips, tongue or any other parts of the body
  • rash, itching or hives on the skin
    Always check the ingredients to make sure you can take this medicine.
  • you have had a reaction affecting your liver while you were taking a medicine containing flucloxacillin.
    Examples of liver reactions include hepatitis and jaundice (yellowing of the eyes or skin).

Do not use this medicine in your eyes.

Do not take this medicine after the expiry date printed on the pack or if the packaging is torn or shows signs of tampering.

If it has expired or is damaged, return to your pharmacist for disposal.

If you are not sure whether you should start taking this medicine, talk to your doctor.

Check with your doctor if you:

  • have allergies to any other medicines, foods, preservatives or dyes
  • have or have had any of the following medical conditions:
    - liver problems
    - kidney problems
    - jaundice, yellowing of the skin or eyes
    - asthma, hayfever, eczema or other allergic conditions
  • take any medicines for any other conditions
  • are pregnant or plan to become pregnant or are breast-feeding.

During treatment, you may be at risk of developing certain side effects. It is important you understand these risks and how to monitor for them. See additional information under Section 6. Are there any side effects?

Pregnancy and breastfeeding

Check with your doctor if you are pregnant or intend to become pregnant.

Talk to your doctor if you are breastfeeding or intend to breastfeed.

Your doctor can discuss with you the risks and benefits involved.

The active ingredient in STAPHYLEX passes into breast milk and there is a possibility that your baby may be affected.

If you have not told your doctor about any of the above, tell them before you start taking STAPHYLEX.

3. What if I am taking other medicines?

Tell your doctor or pharmacist if you are taking any other medicines, including any medicines, vitamins or supplements that you buy without a prescription from your pharmacy, supermarket or health food shop.

Some medicines and STAPHYLEX may interfere with each other. These include:

  • probenecid, a medicine commonly used to treat gout
  • oral contraceptive pills, medicines used for contraception. You should use other birth control methods while you are taking STAPHYLEX.
  • methotrexate, a medicine used to treat inflammatory conditions, including severe psoriasis and active rheumatoid arthritis
  • warfarin, a medicine used to prevent blood clotting.
  • voriconazole, a medicine used to treat serious fungal or yeast infections
  • paracetamol, a medicine used to treat fever and mild to moderate pain.
    Tell your doctor or pharmacist if you are taking STAPHYLEX in combination with paracetamol, particularly if you have impaired kidney function.

These medicines may be affected by STAPHYLEX or may affect how well it works. You may need different amounts of your medicine, or you may need to take different medicines. Your doctor or pharmacist has more information on medicines to be careful with or avoid whilst taking this medicine.

Check with your doctor or pharmacist if you are not sure about what medicines, vitamins or supplements you are taking and if these affect STAPHYLEX.

4. How do I take STAPHYLEX?

How much to take

  • Usual adult dose: 250 mg every 6 hours
  • Usual child dose:
    - 2 to 10 years: half of the adult dose
    - Under 2 years: quarter of the adult dose
  • Follow the instructions provided when STAPHYLEX was prescribed, including the number of days it should be taken.
  • Follow all directions given to you by your doctor or pharmacist carefully. They may differ from the information contained in this leaflet.
    If you do not understand the instructions on the box, ask your doctor or pharmacist for help.

When to take STAPHYLEX

  • STAPHYLEX should be taken 30 minutes to 1 hour before food.
    Food can interfere with the absorption of STAPHYLEX.

How to take STAPHYLEX

  • Swallow the capsules whole with a full glass of water.

How long to take STAPHYLEX

Continue taking your medicine until you finish the pack, or for as long as your doctor tells you.

It is important to keep taking your medicine even if you feel well.

If you forget to take STAPHYLEX

STAPHYLEX should be taken regularly at the same time each day.

If you miss your dose at the usual time and it is almost time for your next dose, skip the dose you missed and take your next dose when you are meant to.

Otherwise, take the missed dose as soon as you remember, and then go back to taking your tablets as you would normally.

Do not take a double dose to make up for the dose you missed.

If you are not sure what to do, ask your doctor or pharmacist.

If you have trouble remembering to take your medicine, ask your pharmacist for some hints.

If you take too much STAPHYLEX

If you think that you or anyone else may have taken too much STAPHYLEX, urgent medical attention may be needed.

You should immediately:

  • phone the Poisons Information Centre
    (Australia telephone 13 11 26) for advice, or
  • contact your doctor, or
  • go to the Emergency Department at your nearest hospital.

You should do this even if there are no signs of discomfort or poisoning.

Symptoms of an overdose may include diarrhoea and nausea.

5. What should I know while taking STAPHYLEX?

Things you should do

  • Before starting any new medicine, tell your doctor or pharmacist that you are taking STAPHYLEX.
  • Remind any doctor, dentist or pharmacist you visit that you are taking STAPHYLEX.
  • If you get a sore, white mouth or tongue while taking or soon after stopping STAPHYLEX, tell your doctor. Also tell your doctor if you get vaginal itching or discharge.
    This may mean you have a fungal infection called thrush. Sometimes, the use of STAPHYLEX allows fungi to grow and the above symptoms to occur. STAPHYLEX does not work against fungi.
  • If you are taking STAPHYLEX for a long time, visit your doctor regularly so that they can check on your progress.
    You may need to have tests to check your liver and kidney function.

Call your doctor straight away if you:

  • become pregnant while taking this medicine.
  • notice your symptoms do not improve within a few days, or if they become worse.
  • develop yellow eyes or skin (jaundice) whilst or soon after taking STAPHYLEX.
    Do this even if it occurs several weeks after you have stopped taking STAPHYLEX.
    Jaundice may mean that you have a serious condition affecting your liver. You may need urgent medical care.
  • get severe diarrhoea.
    Do this even if it occurs several weeks after you have stopped taking STAPHYLEX.
    Diarrhoea may mean that you have a serious condition affecting your bowel. You may need urgent medical care. Do not take any diarrhoea medicine without checking with your doctor.
  • get severe skin reactions with painful red areas, large blisters, peeling of skin layers; fever, chills, aching muscles, feeling unwell. Stop taking this medicine immediately.

Things you should not do

  • Do not take any medicine for diarrhoea without first checking with your doctor or pharmacist.
  • Do not take STAPHYLEX to treat any other conditions unless your doctor tells you to.
  • Do not give STAPHYLEX to anyone else, even if they have the same condition as you.
  • Do not stop taking your medicine or lower the dosage without checking with your doctor.
    If you stop taking it suddenly, your condition may worsen.

Driving or using machines

Be careful before you drive or use any machines or tools until you know how STAPHYLEX affects you.

Things to be aware of

STAPHYLEX can cause jaundice (yellowing of skin and/or eyes) and severe liver damage.

This is more frequent in older patients, particularly those over 55 years of age, and those who take the medicine for more than 14 days.

Immediately contact your doctor if you notice any yellowing of your eyes or skin.

Looking after your medicine

  • Keep your capsules in a cool dry place where the temperature stays below 25°C.

Follow the instructions in the carton on how to take care of your medicine properly.

Store it in a cool dry place away from moisture, heat or sunlight; for example, do not store it:

  • in the bathroom or near a sink, or
  • in the car or on window sills.

Heat and dampness can destroy some medicines.

Keep it where young children cannot reach it.

A locked cupboard at least one-and-a-half metres above the ground is a good place to store medicines.

Getting rid of any unwanted medicine

If you no longer need to take this medicine or it is out of date, take it to any pharmacy for safe disposal.

Do not take this medicine after the expiry date.

6. Are there any side effects?

Tell your doctor or pharmacist as soon as possible if you do not feel well while you are taking STAPHYLEX.

STAPHYLEX treats infections in most people, but it may have unwanted side effects in some people.

All medicines can have side effects. If you do experience any side effects, most of them are minor and temporary. However, some side effects may need medical attention.

Do not be alarmed by this list of possible side effects. You may not experience any of them.

See the information below and, if you need to, ask your doctor or pharmacist if you have any further questions about side effects.

Less serious side effects

Less serious side effectsWhat to do
  • nausea
  • vomiting or an upset stomach
  • diarrhoea
  • a mild rash
  • oral thrush (white, furry sore tongue and mouth)
  • vaginal thrush (sore and itchy vagina and/or vaginal discharge)
Tell your doctor or pharmacist if you have any of these less serious side effects and they worry you.

Serious side effects

Serious side effectsWhat to do
  • any type of skin rash, itching or hives
  • swelling of the face, lips, tongue or other parts of the body
  • shortness of breath, wheezing or troubled breathing
Stop taking STAPHYLEX and tell your doctor immediately, or go to Accident and Emergency at the nearest hospital if you notice any of these serious side effects.

Very serious side effects

Very serious side effectsWhat to do
  • watery and severe diarrhoea, which may also be bloody
  • severe stomach cramps
  • tiredness, headaches, being short of breath when exercising, dizziness and looking pale
  • bleeding or bruising more easily than normal
  • frequent infections such as fever, chills, sore throat or mouth ulcers
  • yellowing of the eyes or skin (jaundice)
  • painful, swollen joints
  • aching muscles, muscle tenderness or weakness, not caused by exercise
  • irregular heart beat
  • dark or cloudy urine, blood in the urine
Tell your doctor immediately, or go straight to the Emergency Department at your nearest hospital if you notice any of these very serious side effects.
You may need urgent medical attention or hospitalisation.

Tell your doctor or pharmacist if you notice anything else that may be making you feel unwell.

Other side effects not listed here may occur in some people.

After stopping STAPHYLEX

Tell your doctor if your skin and/or eyes have turned yellow (jaundice) whilst or soon after you finish taking STAPHYLEX.

Tell your doctor immediately if you notice any of the following side effects, even if they occur up to several weeks after finishing treatment with STAPHYLEX:

  • watery and severe diarrhoea, which may also be bloody
  • severe abdominal cramps or stomach cramps
  • fever, in combination with one or both of the above

These are rare but serious side effects. STAPHYLEX can change the bacteria (which are normally present in the bowel and are harmless) to multiply and therefore cause the above symptoms. You may need urgent medical attention.

Reporting side effects

After you have received medical advice for any side effects you experience, you can report side effects to the Therapeutic Goods Administration online at www.tga.gov.au/reporting-problems. By reporting side effects, you can help provide more information on the safety of this medicine.

Always make sure you speak to your doctor or pharmacist before you decide to stop taking any of your medicines.

7. Product details

This medicine is only available with a doctor's prescription.

What STAPHYLEX contains

Active ingredient
(main ingredient)
flucloxacillin sodium monohydrate 250 mg or 500 mg per capsule
Other ingredients
(inactive ingredients)
  • povidone
  • purified talc
  • sodium starch glycollate
  • microcrystalline cellulose
  • magnesium stearate
  • iron oxide yellow
  • iron oxide red
  • brilliant blue FCF
  • titanium dioxide
  • gelatin
Potential allergenstrace amounts of sulfites

Do not take this medicine if you are allergic to any of these ingredients.

What STAPHYLEX looks like

STAPHYLEX 250 mg is a Size 2 capsule with yellow body and black cap. (AUST R 17683).

STAPHYLEX 500 mg is a Size 0 capsule with yellow body and black cap. (AUST R 17684)

STAPHYLEX is available in blister packs of 24 capsules.

Who distributes STAPHYLEX

Alphapharm Pty Ltd trading as Viatris
Level 1, 30 The Bond
30-34 Hickson Road
Millers Point NSW 2000
www.viatris.com.au
Phone: 1800 274 276

This leaflet was prepared in July 2024.

STAPHYLEX® is a Viatris company trade mark

STAPHYLEX_cmi\Jul24/00

Published by MIMS September 2024

BRAND INFORMATION

Brand name

Staphylex

Active ingredient

Flucloxacillin

Schedule

S4

 

1 Name of Medicine

Flucloxacillin sodium monohydrate.

2 Qualitative and Quantitative Composition

Each Staphylex capsule contains 250 mg or 500 mg of flucloxacillin (as sodium monohydrate) as the active ingredient.

Excipients with known effect.

Trace amounts of sulfites.
For the full list of excipients, see Section 6.1 List of Excipients.

3 Pharmaceutical Form

Staphylex 250 mg capsule.

Size 2 capsule with yellow body and black cap.

Staphylex 500 mg capsule.

Size 0 capsule with yellow body and black cap.

4 Clinical Particulars

4.1 Therapeutic Indications

Treatment of confirmed or suspected staphylococcal and other Gram positive coccal infections including pneumonia, osteomyelitis, skin and soft tissue and wound infections, infected burns, cellulitis.

4.2 Dose and Method of Administration

Dosage (dose and interval).

Usual adult dose. 250 mg, 6 hourly.
Children 2 to 10 years. Half adult dose.

Note.

In severe infections the dosage may be increased.

Method of administration.

The oral dose should be administered half to one hour before meals.

Dosage adjustment.

Renal impairment.

As flucloxacillin sodium monohydrate is excreted to a large extent by the kidney, the dose or dose interval may need modification in patients with renal failure, as the half-life in these patients is increased. Dosage recommendations for various plasma creatinine levels for patients with impaired renal function are not available. Flucloxacillin sodium monohydrate is not significantly removed by haemodialysis.

Hepatic impairment.

Adjustment of dosage may not be necessary as flucloxacillin sodium monohydrate is not metabolised in the liver to any appreciable extent. However, during prolonged treatment, it is advisable to check periodically for hepatic dysfunction (see Section 4.4 Special Warnings and Precautions for Use).

4.3 Contraindications

Staphylex is contraindicated for:
Patients who are hypersensitive to beta-lactam antibiotics (e.g. penicillins, cephalosporins).
Patients with a previous history of flucloxacillin sodium monohydrate associated jaundice/ hepatic dysfunction.
Use in the eye.

4.4 Special Warnings and Precautions for Use

High anion gap metabolic acidosis.

Caution is advised when flucloxacillin sodium monohydrate is administered concomitantly with paracetamol due to the increased risk of high anion gap metabolic acidosis (HAGMA). Patients at high risk for HAGMA are in particular those with severe renal impairment, sepsis or malnutrition especially if the maximum daily doses of paracetamol are used.
After co-administration of flucloxacillin sodium monohydrate and paracetamol, close monitoring is recommended in order to detect the appearance of acid-base disorders, namely HAGMA, including testing for urinary 5-oxoproline.
If flucloxacillin sodium monohydrate is continued after cessation of paracetamol, it is advisable to ensure that there are no signals of HAGMA, as there is a possibility of flucloxacillin sodium monohydrate maintaining the clinical picture of HAGMA. (See Section 4.5 Interactions with Other Medicines and Other Forms of Interactions; Section 4.8 Adverse Effects (Undesirable Effects)).

Severe cutaneous adverse reactions.

Severe cutaneous adverse reactions (SCAR), such as Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalised exanthematous pustulosis (AGEP) have been reported in patients taking beta-lactam antibiotics. When SCAR is suspected, flucloxacillin sodium monohydrate should be discontinued immediately and an alternative treatment should be considered.
The occurrence at the treatment initiation of a feverish generalised erythema associated with pustula may be a symptom of AGEP. In case of AGEP diagnosis, flucloxacillin sodium monohydrate should be discontinued and any subsequent administration of flucloxacillin sodium monohydrate contraindicated.
It should be recognised that each 1 g of flucloxacillin sodium monohydrate contains sodium 2.2 mmol. This should be included in the daily allowance of patients on sodium restricted diets.

Use in hepatic impairment.

Hepatitis.

Warning.

Hepatitis, predominantly of cholestatic jaundice, which may be protracted, has been reported with flucloxacillin sodium monohydrate therapy (see Section 4.8 Adverse Effects (Undesirable Effects)). Reports have been more frequent with increasing age (particularly over 55 years of age) or following prolonged treatment (beyond 14 days). Jaundice may appear several weeks after therapy; in several cases, the course of the reactions has been protracted and lasted for several months. Resolution has occurred with time in most cases. In rare cases, deaths have been reported, nearly always in patients with serious underlying disease or receiving concomitant medication.
During long-term treatments regular monitoring of hepatic function is recommended.
Flucloxacillin sodium monohydrate should be used with caution in patients with evidence of hepatic dysfunction, even though this is not a recognised predisposing factor to hepatic reactions to the drug.

Use in renal impairment.

During long-term treatments, regular monitoring of renal function is recommended. Also see Section 4.2 Dose and Method of Administration, Dosage adjustment, Renal impairment.

Hypersensitivity and anaphylaxis.

Serious and occasionally fatal hypersensitivity (anaphylaxis) reactions have been reported in patients receiving beta-lactam antibiotics e.g. penicillins. Although anaphylaxis is more frequent following parenteral therapy, it has occurred in patients on oral therapy. Before commencing therapy with any beta-lactam antibiotic, careful enquiry should be made concerning previous hypersensitivity reactions to penicillins, cephalosporins or other allergens. If a hypersensitivity reaction occurs, appropriate therapy should be instituted and Staphylex therapy discontinued.
Serious anaphylactoid reactions require emergency treatment with adrenaline. Oxygen, intravenous steroids and airway management including intubation should also be administered as indicated.

Antibiotic associated pseudomembranous colitis.

Antibiotic associated pseudomembranous colitis has been reported with many antibiotics including flucloxacillin sodium monohydrate. A toxin produced with Clostridium difficile appears to be the primary cause. The severity of the colitis may range from mild to life threatening. It is important to consider this diagnosis in patients who develop diarrhoea or colitis in association with antibiotic use (this may occur up to several weeks after cessation of antibiotic therapy). Mild cases usually respond to drug discontinuation alone. However, in moderate to severe cases, appropriate therapy with a suitable oral antibacterial agent effective against Clostridium difficile should be considered. Fluids, electrolytes and protein replacement should be provided when indicated. Drugs which delay peristalsis, e.g. opiates and diphenoxylate with atropine may prolong and/or worsen the condition and should not be used.
Caution should be exercised in the treatment of patients with an allergic diathesis.

Use in the elderly.

No data available.

Paediatric use.

Use in neonates.

Animal studies show that high doses of flucloxacillin sodium monohydrate reduce albumin-bound bilirubin to 50 to 70% of the base line concentration. The drug should therefore be used with extreme caution in jaundiced neonates or premature infants.

Effects on laboratory tests.

No data available.

4.5 Interactions with Other Medicines and Other Forms of Interactions

Paracetamol.

Caution should be taken when flucloxacillin sodium monohydrate is used concomitantly with paracetamol as concurrent intake has been associated with high anion gap metabolic acidosis, especially in patients with risk factors (see Section 4.4 Special Warnings and Precautions for Use; Section 4.8 Adverse Effects (Undesirable Effects)).

Probenecid.

Probenecid decreases the renal tubular secretion of flucloxacillin sodium monohydrate. Concurrent use with Staphylex may result in increased and prolonged blood levels of flucloxacillin sodium monohydrate.

Oral contraceptives.

In common with other antibiotics, patients should be warned that Staphylex may reduce the effectiveness of oral contraceptives.

Methotrexate and warfarin.

Flucloxacillin may require dose adjustment when used in combination with methotrexate and warfarin. Cases have been reported, in which the efficacy of warfarin decreased during concomitant oral treatment with flucloxacillin.

Voriconazole.

Flucloxacillin has been reported to significantly decrease plasma voriconazole concentrations. If concomitant administration of flucloxacillin and voriconazole cannot be avoided, monitor patient for potential loss of voriconazole effectiveness. An increased dose of voriconazole may be required.

4.6 Fertility, Pregnancy and Lactation

Effects on fertility.

No data available.
(Category B1)
The safety of Staphylex in the first trimester of pregnancy has not yet been established. Animal studies with flucloxacillin sodium monohydrate have shown no teratogenic effects. The product has been in clinical use since 1970 and the limited number of reported cases of use in human pregnancy have shown no evidence of untoward effect. Flucloxacillin sodium monohydrate should not be used in pregnancy unless considered essential by the physician.
Flucloxacillin sodium monohydrate is excreted in breast milk in trace amounts. In nursing mothers, an alternative feeding method is recommended because of the risk of allergic sensitisation in the infant.

4.7 Effects on Ability to Drive and Use Machines

The effects of this medicine on a person's ability to drive and use machines were not assessed as part of its registration.

4.8 Adverse Effects (Undesirable Effects)

As with all penicillins, the possibility of hypersensitivity reactions should always be considered. Reactions are more likely to occur in those with an allergic diathesis. Anaphylactic shock is most likely to occur with injected penicillins (see Section 4.4 Special Warnings and Precautions for Use).
The following adverse reactions have been reported as associated with the use of flucloxacillin sodium monohydrate.

Metabolism and nutrition disorders.

Postmarketing experience: very rare cases of high anion gap metabolic acidosis, when flucloxacillin sodium monohydrate is used concomitantly with paracetamol, generally in the presence of risk factors (see Section 4.4 Special Warnings and Precautions for Use; Section 4.5 Interactions with Other Medicines and Other Forms of Interactions).

Skin and other subcutaneous tissue disorders.

Severe cutaneous adverse reactions, including SJS, TEN, DRESS, and acute AGEP (red, scaly rash with bumps under the skin and blisters) have been reported in beta-lactam antibiotics. Adverse reaction of pruritus has been reported very rarely.

Central nervous system.

Adverse effects have been reported rarely. They include dizziness and convulsions. Convulsions may occur in patients with impaired renal function or in those receiving high doses. As the blood brain barrier becomes more permeable in meningitis, toxic symptoms may be precipitated by lower levels of flucloxacillin sodium monohydrate in patients with meningitis.

Gastrointestinal.

Nausea, vomiting, diarrhoea, dyspepsia, abdominal pain. As with other antibiotics, pseudomembranous colitis has rarely been reported (see Section 4.4 Special Warnings and Precautions for Use).

Haematological.

Haemolytic anaemia has been reported during therapy with flucloxacillin sodium monohydrate. Reactions such as anaemia, thrombocytopenia, thrombocytopenic purpura, eosinophilia, leucopenia, neutropenia and agranulocytosis have been reported during therapy with penicillins. These reactions are usually reversible on discontinuation of therapy and are believed to be hypersensitivity phenomena.

Hepatic.

Cases of hepatitis and cholestatic jaundice (occasionally severe) have been reported (see Section 4.4 Special Warnings and Precautions for Use). These may be delayed for up to two months post treatment. A frequency of about 1 in 15,000 exposures have been reported for cholestatic jaundice. Changes in liver function tests may occur but are reversible when treatment is discontinued.

Hypersensitivity reactions.

Erythematous maculopapular rashes, urticaria, purpura, eosinophilia, angioneurotic oedema. Anaphylaxis and erythema multiforme have been reported rarely. Certain reactions (fever, arthralgia, myalgia) sometimes develop more than 48 hours after the start of treatment. Whenever such reactions occur, Staphylex should be discontinued. (Note: urticaria, other skin rashes and serum sickness-like reactions may be controlled with antihistamines and, if necessary, systemic corticosteroids).

Renal.

Cases of nephritis, interstitial nephritis and haematuria have been reported.

Other.

Vaginal or oral moniliasis may occur following the use of antibiotics.
Amongst the adverse events reported spontaneously to Adverse Drug Reactions Advisory Committee (ADRAC), 61% were dermatological effects, 17% were jaundice, 16% were gastrointestinal reactions and 2.5% were CNS related.

Reporting suspected adverse effects.

Reporting suspected adverse reactions after registration of the medicinal product is important. It allows continued monitoring of the benefit-risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions at www.tga.gov.au/reporting-problems.

4.9 Overdose

No information is available, but it could be anticipated that overdosage with oral flucloxacillin sodium monohydrate would cause gastrointestinal and CNS symptoms (see Section 4.8 Adverse Effects (Undesirable Effects)). As the blood brain barrier becomes more permeable in meningitis, toxic symptoms may be precipitated by lower levels of flucloxacillin sodium monohydrate in patients with meningitis.
Flucloxacillin sodium monohydrate is not significantly removed from the circulation by haemodialysis. General supportive measures should be instituted, and consideration given to the use of activated charcoal to minimise gastrointestinal absorption.
For information on the management of overdosage, contact the Poison Information Centre on 13 11 26 (Australia).

5 Pharmacological Properties

5.1 Pharmacodynamic Properties

Mechanism of action.

Microbiology.

Staphylex is a narrow spectrum antibiotic with considerable activity against the following common Gram positive organisms: penicillinase producing Staphylococcus aureus, penicillin sensitive Staphylococcus aureus, β-haemolytic Streptococci (Streptococcus pyogenes), Diplococcus pneumoniae.
It is not active against Gram negative bacilli, methicillin resistant Staphylococcus aureus (MRSA) nor Streptococcus faecalis.

Clinical trials.

No data available.

5.2 Pharmacokinetic Properties

Absorption.

Staphylex is well absorbed following oral administration, with active levels being reached within half an hour, and peak levels within one hour. In the presence of food in the gastrointestinal tract, the absorption of Staphylex is delayed, resulting in lower peak serum levels.

Distribution.

Staphylex, like other isoxazolyl penicillins, is highly bound to serum proteins (> 92%). The low MICs of flucloxacillin sodium monohydrate against Gram positive cocci and the free antibiotic levels achieved, however, ensure that Staphylex is fully active against susceptible pathogens.

Excretion.

The major route of excretion is renal (by both glomerular filtration and tubular secretion) and high levels of active antibiotic are produced in the urine. In the first six hours following oral administration, approximately 50% of the dose can be recovered unchanged in the urine. When probenecid is given together with flucloxacillin sodium monohydrate, the excretion of flucloxacillin sodium monohydrate is delayed, resulting in higher and more prolonged blood levels of the antibiotic.

5.3 Preclinical Safety Data

Genotoxicity.

No data available.

Carcinogenicity.

No data available.

6 Pharmaceutical Particulars

6.1 List of Excipients

Povidone, purified talc, sodium starch glycolate, microcrystalline cellulose, magnesium stearate, iron oxide yellow, iron oxide red, brilliant blue FCF, titanium dioxide and gelatin.

6.2 Incompatibilities

Incompatibilities were either not assessed or not identified as part of the registration of this medicine.

6.3 Shelf Life

In Australia, information on the shelf life can be found on the public summary of the Australian Register of Therapeutic Goods (ARTG). The expiry date can be found on the packaging.

6.4 Special Precautions for Storage

Store below 25°C.
Staphylex capsules should be kept in a well closed container and stored in a dry place.

6.5 Nature and Contents of Container

Container type: PVC/PE/PVDC/Al blister packs.
Pack sizes: 24 or 30 tablets.
Some strengths, pack sizes and/or pack types may not be marketed.

Australian register of therapeutic goods (ARTG).

AUST R 17683 - Staphylex 250 flucloxacillin 250 mg (as sodium) capsule blister pack.
AUST R 17684 - Staphylex 500 flucloxacillin 500 mg (as sodium) capsule blister pack.

6.6 Special Precautions for Disposal

In Australia, any unused medicine or waste material should be disposed of by taking it to your local pharmacy.

6.7 Physicochemical Properties

Flucloxacillin sodium monohydrate is a narrow spectrum antibiotic belonging to the isoxazolyl group of semi synthetic penicillins. It is acid stable and penicillinase resistant and is closely related to cloxacillin. It is a white or almost white powder and is hygroscopic. It is soluble in 1 part of water, in 2 parts of methanol, in 8 parts of ethanol (96%) and in 8 parts of acetone.

Chemical structure.


Chemical name: 3-(2'-chloro-6'-fluorophenyl)- 5-methyl- 4-isoxazolylpenicillin monohydrate.

CAS number.

The chemical abstracts service (CAS) registry number of the medicine: 1847-24-1.
Molecular formula: C19H16ClFN3NaO5S,H2O.
Molecular weight: 493.9.

7 Medicine Schedule (Poisons Standard)

S4 (Prescription Only Medicine).

Summary Table of Changes